Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alp Aytekin

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary SyndromesChristian Valina, Franz-Josef Neumann, Maurizio Menichelli, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
The Canadian Journal of Cardiology|February 4, 2026
Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vesselsAlp Aytekin, Felix Voll, Fiorenzo Simonetti, et al.
Circulation|October 29, 2020
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionAlp Aytekin, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.
JAMA Cardiology|June 30, 2021
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical TrialJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary SyndromesChristian Valina, Franz-Josef Neumann, Maurizio Menichelli, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
The Canadian Journal of Cardiology|February 4, 2026
Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vesselsAlp Aytekin, Felix Voll, Fiorenzo Simonetti, et al.
Circulation|October 29, 2020
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionAlp Aytekin, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrelAlp Aytekin, Maria Scalamogna, J J Coughlan, et al.
JAMA Cardiology|June 30, 2021
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical TrialJ J Coughlan, Alp Aytekin, Shqipdona Lahu, et al.
Pageof 4